Robert Vink, MD

Affiliations: 
Neurology Department University of California, San Francisco, San Francisco, CA 
Google:
"Robert Vink"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vink R, Nimmo A. (2024) Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury. International Journal of Molecular Sciences. 25
Byard R, Tiemensma M, Buckland ME, et al. (2023) Chronic traumatic encephalopathy (CTE)-features and forensic considerations. Forensic Science, Medicine, and Pathology
Corrigan F, Cernak I, McAteer K, et al. (2021) NK1 antagonists attenuate tau phosphorylation after blast and repeated concussive injury. Scientific Reports. 11: 8861
Sorby-Adams AJ, Leonard AV, Hoving JW, et al. (2019) NK1-r Antagonist Treatment Comparable to Decompressive Craniectomy in Reducing Intracranial Pressure Following Stroke. Frontiers in Neuroscience. 13: 681
Sorby-Adams AJ, Vink R, Turner RJ. (2018) Large animal models of stroke and traumatic brain injury as translational tools. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Plummer SL, Corrigan F, Thornton E, et al. (2018) The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury. Plos One. 13: e0190449
Ameliorate JL, Ghabriel MN, Vink R. (2017) Magnesium enhances the beneficial effects of NK1 antagonist administration on blood-brain barrier permeability and motor outcome after traumatic brain injury. Magnesium Research. 30: 88-97
Vink R, Gabrielian L, Thornton E. (2017) The Role of Substance P in Secondary Pathophysiology after Traumatic Brain Injury. Frontiers in Neurology. 8: 304
Vink R. (2017) Large animal models of traumatic brain injury. Journal of Neuroscience Research
Corrigan F, Arulsamy A, Collins-Praino LE, et al. (2017) Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation. Brain, Behavior, and Immunity
See more...